Subscribe to the BioNews newsletter for free

Advanced Search

Search for
The Progress Educational Trust (PET), informing debate on assisted conception and genetics

Like the Progress Educational Trust on Facebook



EVENTS

What Does Consent Mean for Generation Genome?

Progress Educational Trust
Nowgen Centre, 29 Grafton Street, Manchester M13 9WU
11 September 2017 6.30pm-8.30pm (registration opens at 6pm)
A free-to-attend public event in Manchester about genomic medicine and consent, produced by the Progress Educational Trust (PET) in partnership with Genomics England and chaired by Professor William Newman (Director of the Manchester Centre for Genomic Medicine).
Speakers include Professor Sue Hill (Chief Scientific Officer at NHS England), Professor Anneke Lucassen (coauthor of the ethics chapter in the Chief Medical Officer's new Generation Genome report) and Dr Tara Clancy (Consultant Genetic Counsellor at the Manchester Centre for Genomic Medicine).
Attendance is free, but advance booking is required. Book your place now by emailing
If tweeting about this event, please use the hashtag #PETgenomic
This event is taking place during NHS England's Health and Care Innovation Expo (which is being held at a different venue, see this map for directions from one venue to the other) but attendance is open to everyone regardless of whether or not you are registered to attend the Expo.
This event also forms part of the Genomics Conversation programme led by Genomics England, and follows the success of the recent event 'What Next for Genomics? Providing Answers, Changing Lives, Transforming the NHS'. Watch a film of that event here.

Consent - a conscious process of granting permission or approval - is one of the most important concepts in all of medicine, and plays a vital role when patients consent to receive particular treatments or undergo particular tests.
Consent is also vitally important when research participants consent to certain uses of the samples they provide, or to uses of the data generated by analysing these samples. Increasingly, such data may include the patient's whole genome sequence, which may in turn be linked to the patient's lifetime health and medical records.
Genomic medicine - an approach to medicine in which our genomic information plays a central role in understanding, preventing, diagnosing and treating disease - may require, or may result in, changes to the way we discuss and understand consent.
The new Generation Genome report from the UK's Chief Medical Officer calls for 'a short, simple, understandable and workable consent process for patients to choose how confidential genomic data about them is used'.
Another new report from the UK's National Data Guardian says work is needed 'to explore how the consent process might cover both direct and indirect care purposes as genetic and genomic medicine become a more routine part of care for a greater number of NHS patients'.
This public event will see experts with contrasting perspectives discuss consent as it relates to genomic medicine, the UK's 100,000 Genomes Project, the Chief Medical Officer and National Data Guardian reports, and wider developments. Questions explored will include:
Is it possible to ensure that a consent process is thorough, meaningful and leaves the patient well-informed, without it becoming so detailed and onerous that it results in disproportionate burdens or impediments - for patients, clinicians and researchers alike?
What uses of genomic data - and what constraints on such uses - are reasonable and foreseeable, after a patient has consented to use of the data? In what circumstances would additional consent need to be sought from the patient? What scope exists for patients to change their mind, and what are the possible consequences - for them and for others - if they do so?
Where, when and how should consent be taken? It is common at present for consent to be taken using paper forms, during a face-to-face discussion in a hospital or clinic. But consent can also be taken electronically, and face-to-face discussions may not always be necessary or practical (for example, if additional consent is sought over the course of a long-term project).
What are the implications for consent, if clinical services and research projects are combined (as in the 100,000 Genomes Project)? Are such arrangements likely to become more common? To what extent could treatment become dependent on the genomic data of large numbers of patients, and draw upon this data in real time (rather than relying on intermittent research publications)?
What are the rules, regulations, standards and laws that govern consent, in the UK and internationally? How do they apply in cases of cross-border treatment, or cross-border research collaboration?
What legal, technical and professional assurances can be given about the security, identifiability and uses of genomic data? How can members of the lay public be expected to assess these assurances? Where can the public seek reliable advice on the matter, and to whom can they report any concerns or complaints about the use of their data?
Do we need to rethink the way consent relates to individuals and families? Our genomic data may have implications for our blood relatives, and vice versa. It is already the case in genomics that treatment and research can mean involving family members, and seeking their consent. But it is also technically possible to infer some facts about our relatives from our genomic data without their knowledge or consent.
In the PET tradition, much of the event's running time will be devoted to letting the audience put questions and comments to the speakers.

SPEAKERS INCLUDE

Professor Sue Hill Professor Sue Hill, Chief Scientific Officer at NHS England and speaker at the Progress Educational Trust's FREE-to-attend event 'What Does Consent Mean for Generation Genome?', taking place at the Nowgen Centre in Manchester on the evening of Monday 11 September 2017
Chief Scientific Officer at NHS England
Senior Responsible Officer for the NHS Genomics Programme

Anneke Lucassen Anneke Lucassen, Professor of Clinical Genetics at the University of Southampton and speaker at the Progress Educational Trust's FREE-to-attend event 'What Does Consent Mean for Generation Genome?', taking place at the Nowgen Centre in Manchester on the evening of Monday 11 September 2017
Professor of Clinical Genetics and Leader of the Clinical Ethics and Law research group at the University of Southampton, and Honorary Consultant in Clinical Genetics at the Wessex Clinical Genetics Service
Coauthor of the ethics chapter in the Chief Medical Officer's report Generation Genome, and contributor to the National Data Guardian's report Developing a Consensus on Data Sharing to Support NHS Clinical Genetics and Genomics Services

Dr Tara Clancy Dr Tara Clancy, Consultant Genetic Counsellor at the Manchester Centre for Genomic Medicine and speaker at the Progress Educational Trust's FREE-to-attend event 'What Does Consent Mean for Generation Genome?', taking place at the Nowgen Centre in Manchester on the evening of Monday 11 September 2017
Consultant Genetic Counsellor and Honorary Senior Lecturer at the Manchester Centre for Genomic Medicine
Member of the Nuffield Council on Bioethics

CHAIR

William Newman Professor William Newman, Director of the Manchester Centre for Genomic Medicine and chair of the Progress Educational Trust's FREE-to-attend event 'What Does Consent Mean for Generation Genome?', taking place at the Nowgen Centre in Manchester on the evening of Monday 11 September 2017
Professor of Translational Genomic Medicine at the University of Manchester, and Honorary Consultant at St Mary's Hospital
Director of the Manchester Centre for Genomic Medicine for the 100,000 Genomes Project

PARTNERS AND SUPPORTERS

Genomics England, joint organiser of the Progress Educational Trust's FREE-to-attend event 'What Does Consent Mean for Generation Genome?', taking place at the Nowgen Centre in Manchester on the evening of Monday 11 September 2017

Datalabel The UK's Leading Supplier Of Medical Labels & Asset Labels

Subscribe to BioNews for FREE HERE
 
Good Fundraising Code
 
Find out more about the Progress Educational Trust by downloading our brochure HERE

Advertising & sponsorship
Terms & conditions
Sitemap

Progress Educational Trust, 140 Grays Inn Road, London WC1X 8AX, UK
Tel: +44 (0)20 7278 7870 Email:
Limited company registered in England and Wales no 7405980
Registered charity no 1139856

Website developed and built by Face to Face
Website designed by Thunder
Website administration

© 1992, 2017
Progress Educational Trust